Coldstream Capital Management Inc Madrigal Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 207 shares of MDGL stock, worth $63,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207Holding current value
$63,420% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
356Shares Held
22.1MCall Options Held
788KPut Options Held
615K-
Janus Henderson Group PLC London, X02.21MShares$676 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$626 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$620 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$611 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$605 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.24B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...